Covered recipient · General Payments record
JOHN M TAYLOR
Allopathic & Osteopathic Physicians Surgery Plastic and Reconstructive Surgery
General Payments · PY2018–2024
$23,013.99
- Reported across 209 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,510.93 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $542.25 | 21 |
| REVANCE THERAPEUTICS, INC. | $375.88 | 7 |
| ConvaTec Inc. | $219.78 | 2 |
| TELA Bio, Inc. | $162.49 | 1 |
| Acera Surgical, Inc. | $160.85 | 1 |
| MERZ NORTH AMERICA, INC. | $18.89 | 1 |
| Pacira Pharmaceuticals Incorporated | $15.95 | 1 |
| Galderma Laboratories, L.P. | $14.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.70 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206507 | CMS |
| ABBVIE INC. | $13.45 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206509 | CMS |
| ABBVIE INC. | $3.68 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206511 | CMS |
| ABBVIE INC. | $5.82 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206513 | CMS |
| ABBVIE INC. | $15.62 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206515 | CMS |
| ABBVIE INC. | $17.59 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206517 | CMS |
| ABBVIE INC. | $4.19 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206519 | CMS |
| ABBVIE INC. | $1.41 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206521 | CMS |
| ABBVIE INC. | $15.60 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206523 | CMS |
| ABBVIE INC. | $22.44 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206525 | CMS |
| ABBVIE INC. | $64.24 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206527 | CMS |
| ABBVIE INC. | $8.36 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206529 | CMS |
| ABBVIE INC. | $37.50 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206531 | CMS |
| ABBVIE INC. | $13.83 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206533 | CMS |
| ABBVIE INC. | $127.15 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206535 | CMS |
| ABBVIE INC. | $18.63 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206537 | CMS |
| ABBVIE INC. | $7.56 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206539 | CMS |
| ABBVIE INC. | $18.16 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206541 | CMS |
| ABBVIE INC. | $20.84 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206543 | CMS |
| ABBVIE INC. | $81.06 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206545 | CMS |
| ABBVIE INC. | $29.42 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106206547 | CMS |
| Acera Surgical, Inc. | $160.85 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152413128 | CMS |
| ConvaTec Inc. | $101.08 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151385928 | CMS |
| ConvaTec Inc. | $118.70 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151385930 | CMS |
| Galderma Laboratories, L.P. | $14.84 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145331803 | CMS |
| MERZ NORTH AMERICA, INC. | $18.89 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146371525 | CMS |
| Pacira Pharmaceuticals Incorporated | $15.95 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151249559 | CMS |
| REVANCE THERAPEUTICS, INC. | $125.00 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930473 | CMS |
| REVANCE THERAPEUTICS, INC. | $21.10 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930475 | CMS |
| REVANCE THERAPEUTICS, INC. | $14.57 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930477 | CMS |
| REVANCE THERAPEUTICS, INC. | $49.69 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930479 | CMS |
| REVANCE THERAPEUTICS, INC. | $76.48 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930481 | CMS |
| REVANCE THERAPEUTICS, INC. | $39.72 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930483 | CMS |
| REVANCE THERAPEUTICS, INC. | $49.32 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930485 | CMS |
| TELA Bio, Inc. | $162.49 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154224710 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.